Concepedia

Author

Guillaume Sicard

Inserm

Also Known As

G A Sicard, G. Sicard, Guillaume Sicard, Sicard, Guillaume

31

Publications

194

Citations

8

H-Index

14

Concepts

All Affiliations

InsermAix-Marseille UniversitéRoche (France)Centre National de la Recherche ScientifiqueHôpital de la Conception
GS

About

Guillaume Sicard is an author at Inserm specializing in cancer therapeutics, nanotherapeutics, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

19

2

Medicine

1

1

19

3

Biomedical Engineering

1

1

19

4

Immunology

1

1

19

5

Pharmacology

1

1

19

Guillaume Sicard

×

5

Publications

116

Citations

5

H-Index

YearCitations

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer

Anne Rodallec, Guillaume Sicard, Sarah Giacometti,

International Journal of Nanomedicine

2018

34

Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer

Guillaume Sicard, Clément Paris, Sarah Giacometti,

Pharmaceutics

2020

23

Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles

Anne Rodallec, Corentin Franco, Stéphane Robert,

Scientific Reports

2020

22

Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3)

Anne Rodallec, Guillaume Sicard, Sarah Giacometti,

Anti-Cancer Drugs

2019

19

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study

Amira Marouf, Anne‐Ségolène Cottereau, Salim Kanoun,

Haematologica

2021

18

Page 1